Standout Papers
- The pro- and anti-inflammatory properties of the cytokine interleukin-6 (2011)
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer (2009)
- IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6 (2012)
- Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer (2011)
- IL-6 and Its Soluble Receptor Orchestrate a Temporal Switch in the Pattern of Leukocyte Recruitment Seen during Acute Inflammation (2001)
- Soluble receptors for cytokines and growth factors: generation and biological function (1994)
- IL-6 pathway in the liver: From physiopathology to therapy (2016)
- TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling (2004)
- The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion (2003)
- A Switch from White to Brown Fat Increases Energy Expenditure in Cancer-Associated Cachexia (2014)
- Interleukin-6 Family Cytokines (2017)
- Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer (2006)
- Soluble gp130 is the natural inhibitor of soluble interleukin‐6 receptor transsignaling responses (2001)
- Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling (2011)
- Interleukin-6: designing specific therapeutics for a complex cytokine (2018)
- Interleukin-6 and its receptors: A highly regulated and dynamic system (2014)
- Repopulating Microglia Promote Brain Repair in an IL-6-Dependent Manner (2020)
- Targeting IL-6 trans-signalling: past, present and future prospects (2023)
- Interleukin-6: obstacles to targeting a complex cytokine in critical illness (2021)
Immediate Impact
11 by Nobel laureates 31 from Science/Nature 124 standout
Citing Papers
Reframing Immune-Mediated Inflammatory Diseases through Signature Cytokine Hubs
2021 Standout
Effective treatment of severe COVID-19 patients with tocilizumab
2020 Standout
Works of Stefan Rose‐John being referenced
Interleukin-6 and its receptors: A highly regulated and dynamic system
2014 Standout
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
2011 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Stefan Rose‐John | 17357 | 18253 | 13501 | 563 | 47.2k | |
| Robert M. Strieter | 16972 | 23746 | 12590 | 505 | 56.2k | |
| Kouji Matsushima | 12827 | 25342 | 11715 | 556 | 48.5k | |
| Steven L. Kunkel | 9731 | 21415 | 9559 | 524 | 47.5k | |
| Joost J. Oppenheim | 11389 | 28632 | 15004 | 448 | 53.5k | |
| Jo Van Damme | 13567 | 16549 | 12546 | 540 | 41.1k | |
| Marc Feldmann | 7826 | 23651 | 11157 | 554 | 52.9k | |
| John J. O’Shea | 14988 | 30779 | 10988 | 321 | 48.8k | |
| Paola Allavena | 21665 | 32722 | 14347 | 289 | 55.6k | |
| Tadamitsu Kishimoto | 25455 | 33603 | 21971 | 633 | 76.3k | |
| Josef Penninger | 14525 | 17755 | 40322 | 578 | 76.7k |
All Works
Login with ORCID to disown or claim papers
Loading papers...